A new 5-gene signature predictive of risk of relapse in early breast cancer.
Giorgio Mustacchi
Consultant or Advisory Role - AlphaGenics
Honoraria - Celgene; Novartis; Roche
Research Funding - AlphaGenics
Luca Morandi
No relevant relationships to disclose
Mariapia Sormani
No relevant relationships to disclose
Alessandra Gennari
No relevant relationships to disclose
Fabrizio Zanconati
No relevant relationships to disclose
Daniela Bonifacio
No relevant relationships to disclose
Adriana Monzoni
Employment or Leadership Position - AlphaGenics
Paolo Bruzzi
No relevant relationships to disclose